PhRMA taps Tauzin for top post

The Pharmaceutical Research and Manufacturers of America (PhRMA) confirmed Billy Tauzin to succeed Alan Holmer as president and chief executive.
Tauzin, a Louisiana Republican retiring after 12 terms in the House of Representatives, was long rumored to be the PhRMA's choice for the job, but not without controversy. Tauzin's previous role as chairman of the House Energy and Commerce Committee, which oversees the pharmaceutical industry, and his active involvement in crafting the Medicare drug benefit law have drawn criticism from Democrats and government watchdog groups.
PhRMA chairman Miles White called Tauzin "a leader that embodies action," in a statement.
Tauzin will take up his new post on Jan. 3.
You must be a registered member of MMM to post a comment.

Next Article in Careers

Email Newsletters

Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.